Iradimed IRMD Cash Flow Statement (2013-2026)

NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Iradimed Quarterly Cash Flow Statement

Periods 53 quarters
Latest Jun 2026

Iradimed reported cash from operations of $5.94M and free cash flow of $5.75M for the quarter ended Jun 2026, down 23.3% year over year. This cash flow statement covers 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
2.58M3.89M2.49M3.24M3.43M3.67M3.41M4.18M5.07M3.12M4.14M4.90M5.05M4.45M4.69M5.77M5.58M6.37M5.82M5.22M
Share-based CompensationStock Comp.
0.36M0.39M0.45M0.13M0.39M0.43M0.53M0.57M0.53M0.55M0.63M0.61M0.63M0.66M0.83M0.73M0.67M0.70M0.68M0.81M
Deferred Taxes
-0.43M-0.11M0.05M0.09M0.08M-0.28M-0.08M1.14M0.04M0.07M-0.92M1.64M-0.13M0.11M-0.13M-0.13M-0.13M-2.33M0.14M0.13M
Asset Writedowns and ImpairmentWritedown
-0.00M0.07M0.01M0.01M0.03M0.05M0.18M-0.01M0.05M-0.01M0.04M0.07M0.10M-0.30M-0.04M0.01M-0.05M-875.000.04M0.01M
Cash from OperationsCash from Ops.
3.38M3.37M1.43M1.64M3.94M3.04M4.65M3.51M1.39M3.91M3.88M6.64M9.12M5.99M4.29M7.75M6.99M5.92M8.29M5.94M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.39M0.43M0.49M0.44M-0.69M0.18M0.19M0.19M0.21M0.23M0.20M0.20M0.20M0.19M0.21M0.38M0.38M0.46M0.41M
Change in Working Capital
Change in ReceivablesChange Receivables
0.37M0.90M1.38M1.91M2.28M2.67M-1.56M-0.46M1.68M-0.50M0.76M-1.02M-1.70M0.19M2.13M-1.80M2.89M-0.19M-0.21M-0.28M
Change in InventoryChange Inventory
-0.15M0.05M-0.08M0.67M0.32M0.41M1.18M3.03M1.92M1.34M-0.09M-0.49M-0.70M-1.85M0.12M0.75M0.56M-0.05M0.53M0.52M
Change in Account PayablesChange Payables
0.06M0.05M0.19M-0.20M0.05M1.09M0.11M1.60M-1.19M-0.74M-0.64M-0.12M0.29M-0.39M0.69M-0.69M0.43M-0.51M0.36M-0.33M
Change in Accured ExpensesChange Accured Exp.
0.40M0.40M-0.94M0.39M0.08M0.32M-1.26M0.72M-0.04M0.83M-0.63M0.76M0.38M0.49M-1.50M0.94M0.86M-0.85M-1.15M0.99M
Change in TaxesChange Taxes
0.05M-0.41M0.62M0.39M2.33M-0.29M0.75M-0.49M0.03M0.02M0.04M0.70M0.58M-0.79M3.01M-0.23M2.09M-4.41M
Other Working Capital ChangesOther WC Changes
-1.09M-0.27M-0.12M-0.14M-0.20M0.98M-0.08M-0.29M0.77M0.21M-0.27M0.26M-0.05M-0.05M0.55M0.79M0.14M0.12M0.30M0.38M
Investing Activities
Capital ExpendituresCapex
0.15M0.09M0.24M0.23M0.36M0.21M6.40M0.20M0.31M0.53M0.27M1.13M3.81M2.79M3.70M2.64M1.14M0.29M0.40M0.18M
Change in Acquisitions & DivestmentsChange Acquisitions
0.44M
Cash from Investing ActivitiesCash from Investing
-0.22M0.26M-0.42M0.08M-0.56M-0.47M-6.56M-0.38M-0.44M-0.63M-0.48M-1.27M-4.01M-3.06M-3.92M-2.82M-1.26M-0.42M-0.47M-0.44M
Financing Activities
Other financing activitiesOther financing
0.06M0.54M0.07M1.000.07M1.002.000.17M0.03M
Cash from Financing ActivitiesCash from Financing
0.05M0.00M-12.55M-0.01M0.05M-0.20M-13.27M-0.09M-0.03M-0.26M-8.04M-1.96M-1.92M-2.42M-2.28M-2.26M-2.19M-10.87M-2.61M-2.79M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.00M0.00M881.000.00M0.01M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
12.56M13.22M7.98M1.90M1.90M1.90M2.16M2.16M2.16M8.55M2.56M2.56M
Additional items
Change in Cash
3.21M3.63M-11.55M1.71M3.43M2.37M-15.18M3.05M0.92M3.02M-4.64M3.41M3.19M0.51M-1.90M2.67M3.53M-5.37M5.21M2.71M
Free Cash FlowFCF
3.23M3.28M1.18M1.41M3.58M2.83M-1.75M3.31M1.08M3.38M3.61M5.50M5.31M3.20M0.59M5.11M5.85M5.63M7.89M5.75M
Net Cash FlowNCF
3.21M3.63M-11.55M1.71M3.43M2.37M-15.18M3.05M0.92M3.02M-4.64M3.41M3.19M0.51M-1.90M2.67M3.53M-5.37M5.21M2.71M